Premium Information is available for this item - Upgrade for $1 a day
6505-01-223-6152
Usp Tablets Conjugated Estrogens
6505012236152 012236152 NDC0182-0190-01
INC: 30941 Tablets Conjugated Estrogens
January 2023
5
Marketplace 6505-01-223-6152
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-223-6152 5+ Documents (More...)
-01-223-6152 RQST Updated Every /fsg-65/fsc -6505/us 6505-01-223-6152 Estrogens 012236152 Usp Tablets
Usp Tablets Conjugated Estrogens 012236152 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-223-6152
Usp Tablets Conjugated Estrogens 012236152 fsg-65/fsc-6505/us 6505-01-346-9194 Usp Tablets Conjugated
Usp Tablets Conjugated Estrogens 012236152 002598458 fsg-65/fsc-6505/us 6505-01-223-6152 https
Usp Tablets Conjugated Estrogens 012236152 Estrogens 002598458 fsg-65/fsc-6505/us 6505-01-223-6152
Tablets Conjugated Estrogens 219078131 JavaScript in your web browser . 6505-21-907-8131Usp 6505-01-223-6152
Usp Tablets Conjugated Estrogens 012236152 fsg-65/fsc-6505/us 6505-01-346-9194 Usp Tablets Conjugated
65/fsc-6505/us 6505-00-259-8458 Usp Tablets Conjugated Estrogens 002598458 fsg-65/fsc-6505/us 6505-01-223-6152
Usp Tablets Conjugated Estrogens 012236152 6505/us 6505-01-346-9194 Usp Tablets Conjugated https
Estrogens 005840410 Estrogens 012754783 6505-00-003-5111 6505-00-584-0410 Tablets Conjugated Estrogens 012236152
Restrictions 6505-01-223-6152
6505-01-223-6152 is a Usp Tablets Conjugated Estrogens that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-223-6152
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-223-6152
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-223-6152
- Part Number
- Manufacturer
- Status
- NDC0182-0190-01
- Manufacturer
- 63488 - Goldline Laboratories, Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-223-6152
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 1.250 Milligrams Estrogenic Substances, Conjugated Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Therapeutic Equivalent [THPE]
- Goldline Labs
- Special Features [FEAT]
- Coating Feature:Sugar
Management Data 6505-01-223-6152
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jan 1986
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Ea
- 00000000100EA
- K
Similar Supply Items to 6505-01-223-6152
Freight Information 6505-01-223-6152
6505-01-223-6152 has freight characteristics.. 6505-01-223-6152 has a variance between NMFC and UFC when transported by rail and the description should be consulted.